Evaluation of Microinvasive Glaucoma Surgery: MINIject® Versus Hydrus® Microstent in Combination With Cataract Surgery

Recruiting now · Not applicable

Conditions studied: Glaucoma, Cataract

In brief

The study aims to investigate postoperative outcomes after two different MIGS implants (MINIject or Hydrus) in combination with cataract surgery for patients with glaucoma.

Key facts

Study ID

NCT06844292

Run by

Medical University of Graz

People needed

152

Starts

2025-03-03

Expected to finish

2031-03-03

Last updated by the study team

2025-03-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with glaucoma in which surgery is indicated to reach target intraocular pressure as well as lens opacities where CS is indicated
• Clinically eligible for both surgeries
• Subjects not anticipated to require any further surgery in the next 12 months
• Patients' age > 18 years

You may not qualify if…

• Patients who do not want to make follow-ups at the department
• Angle closure, uveitic, neovascular, congenital glaucoma, iridocorneal endothelial syndrome, Axenfeld-Rieger syndrome
• Prior filtering glaucoma surgery, suprachoroidal stent, retinal surgery, corneal graft surgery or cyclophotocoagulation
• Allergy to any drugs or substances required for the protocol
• Pregnant women

Where it is running

• Medical University Graz — Graz, Styria, Austria (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.